Use of Hormone Replacement Therapy in Special Circumstances

被引:0
作者
Goel, Neerja [1 ]
Ranjan, Megha [1 ]
Sharma, Jai Bhagwan [2 ]
Srivastava, Ruchi [1 ]
Vardhan, Shailza [1 ]
机构
[1] Sharda Hosp, SMS & R, Dept Obstet & Gynaecol, Greater Noida, Uttar Pradesh, India
[2] AIIMS, Dept Obstet & Gynaecol, Delhi, India
关键词
Estrogen deficient state; hormone replacement therapy; primary ovarian insufficiency; quality of life; ESTROGEN PLUS PROGESTIN; FOLLOW-UP; VENOUS THROMBOEMBOLISM; POSTMENOPAUSAL WOMEN; ENDOTHELIAL FUNCTION; YOUNG-WOMEN; BONE LOSS; DISEASE; CANCER; RISK;
D O I
10.4103/jmh.jmh_152_24
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The use of hormone replacement therapy (HRT) was quite liberal in the 19th century. The controversial reports given by the World Health Initiative and million women study restricted its use in certain medical conditions. This article has been written to revisit the use of HRT in certain medical conditions where it was earlier contraindicated. In the era of modern medicine, benefits and risks of HRT should be carefully thought of and a holistic treatment approach should be used to provide women the best quality of life she can have in her circumstance. Contraindications to HRT should be reconsidered as the estrogen deficient state might itself give the woman symptoms that could make her overall health even worse. HRT can be safely given in minimum doses, for a restricted period of time in conditions such as breast cancer, genital malignancy, cardiovascular disorders, Alzheimer's disease and thromboembolism and many more medical conditions. Another breakthrough in the past has been the use of HRT in hormone deficient states such as Turner syndrome (TS) and primary ovarian insufficiency (POI). HRT when timely given with growth hormone can prove to be beneficial in cases of both TS and POI.
引用
收藏
页码:6 / 13
页数:8
相关论文
共 54 条
  • [1] Bone loss in young women with karyotypically normal spontaneous premature ovarian failure
    Anasti, JN
    Kalantaridou, SN
    Kimzey, LM
    Defensor, RA
    Nelson, LM
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) : 12 - 15
  • [2] [Anonymous], 2011, NCCN Clinical practice Guidelines in Oncology (NCCN Guidelines): prostate cancer
  • [3] Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
  • [4] Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome
    Bannink, EMN
    Raat, H
    Mulder, PGH
    Keizer-Schrama, SMPFD
    [J]. JOURNAL OF PEDIATRICS, 2006, 148 (01) : 95 - 101
  • [5] ESHRE guideline: endometriosis
    Becker, Christian M.
    Bokor, Attila
    Heikinheimo, Oskari
    Horne, Andrew
    Jansen, Femke
    Kiesel, Ludwig
    King, Kathleen
    Kvaskoff, Marina
    Nap, Annemiek
    Petersen, Katrine
    Saridogan, Ertan
    Tomassetti, Carla
    van Hanegem, Nehalennia
    Vulliemoz, Nicolas
    Vermeulen, Nathalie
    [J]. HUMAN REPRODUCTION OPEN, 2022, 2022 (02)
  • [6] Beral V, 2019, LANCET, V394, P1139, DOI [10.1016/S0140-6736(19)32033-4, 10.1016/S0140-6736(19)32033-1]
  • [7] Hormone therapy and venous thromboembolism among postmenopausal women -: Impact of the route of estrogen administration and progestogens:: The ESTHER study
    Canonico, Marianne
    Oger, Emmanuel
    Plu-Bureau, Genevieve
    Conard, Jacqueline
    Meyer, Guy
    Levesque, Herve
    Trillot, Nathalie
    Barrellier, Marie-Therese
    Wahl, Denis
    Emmerich, Joseph
    Scarabin, Pierre-Yves
    [J]. CIRCULATION, 2007, 115 (07) : 840 - 845
  • [8] Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials
    Chlebowski, Rowan T.
    Anderson, Garnet L.
    Aragaki, Aaron K.
    Manson, JoAnn E.
    Stefanick, Marcia L.
    Pan, Kathy
    Barrington, Wendy
    Kuller, Lewis H.
    Simon, Michael S.
    Lane, Dorothy
    Johnson, Karen C.
    Rohan, Thomas E.
    Gass, Margery L. S.
    Cauley, Jane A.
    Paskett, Electra D.
    Sattari, Maryam
    Prentice, Ross L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (04): : 369 - 380
  • [9] Estrogen plus progestin and colorectal cancer in postmenopausal women
    Chlebowski, RT
    Wactawski-Wende, J
    Ritenbaugh, C
    Hubbell, FA
    Ascensao, J
    Rodabough, RJ
    Rosenberg, CA
    Taylor, VM
    Harris, R
    Chen, C
    Adams-Campbell, LL
    White, E
    Alving, B
    Rossouw, J
    Pottern, L
    Ludlam, S
    McGowan, J
    Prentice, R
    Anderson, G
    LaCroix, A
    Patterson, R
    McTiernan, A
    Cochrane, B
    Hunt, J
    Tinker, L
    Kooperberg, C
    McIntosh, M
    Wang, CY
    Chen, C
    Bowen, D
    Kristal, A
    Stanford, J
    Urban, N
    Weiss, N
    White, E
    Shumaker, S
    Rautaharju, P
    Prineas, R
    Naughton, M
    Stein, E
    Laskarzewski, P
    Cummings, S
    Nevitt, M
    Dockrell, M
    Harnack, L
    Cammarata, F
    Lindenfelser, S
    Psaty, B
    Heckbert, S
    Wassertheil-Smoller, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) : 991 - 1004
  • [10] HORMONE REPLACEMENT THERAPY PREVENTS BONE LOSS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
    CLEMENTS, D
    COMPSTON, JE
    EVANS, WD
    RHODES, J
    [J]. GUT, 1993, 34 (11) : 1543 - 1546